 | • レポートコード：GIR201103296 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、皮膚疾患治療薬の世界市場を調査対象にし、皮膚疾患治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（処方薬、市販薬）、用途別分析（病院薬局、オンライン薬局、小売薬局）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Mylan Pharmaceuticals、Bristol-Myers Squibb、Almirall、Pfizer、PharmaDerm、Roche、GlaxoSmithKline、Barrier Therapeutics、Bausch Health、Galderma、Novartis、Sinclair Pharma ・メーカー別販売量、売上、市場シェア ・皮膚疾患治療薬の地域別市場分析 ・皮膚疾患治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・皮膚疾患治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・皮膚疾患治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・皮膚疾患治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・皮膚疾患治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・皮膚疾患治療薬の種類別市場規模2015-2020：処方薬、市販薬 ・皮膚疾患治療薬の用途別市場規模2015-2020：病院薬局、オンライン薬局、小売薬局 ・皮膚疾患治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Dermatological Disorders Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Dermatological Disorders Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dermatological Disorders Medications market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dermatological Disorders Medications market has been segmented into
Prescription Drugs
Over-The-Counter Drugs
By Application, Dermatological Disorders Medications has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dermatological Disorders Medications market presented in the report. This section sheds light on the sales growth of different regional and country-level Dermatological Disorders Medications markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dermatological Disorders Medications market.
The report offers in-depth assessment of the growth and other aspects of the Dermatological Disorders Medications market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dermatological Disorders Medications Market Share Analysis
Dermatological Disorders Medications competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dermatological Disorders Medications sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dermatological Disorders Medications sales, revenue and market share for each player covered in this report.
The major players covered in Dermatological Disorders Medications are:
Mylan Pharmaceuticals
Bristol-Myers Squibb
Almirall
Pfizer
PharmaDerm
Roche
GlaxoSmithKline
Barrier Therapeutics
Bausch Health
Galderma
Novartis
Sinclair Pharma
Among other players domestic and global, Dermatological Disorders Medications market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatological Disorders Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatological Disorders Medications, with price, sales, revenue and global market share of Dermatological Disorders Medications in 2018 and 2019.
Chapter 3, the Dermatological Disorders Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatological Disorders Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dermatological Disorders Medications market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dermatological Disorders Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Dermatological Disorders Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatological Disorders Medications Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prescription Drugs
1.2.3 Over-The-Counter Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatological Disorders Medications Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Overview of Global Dermatological Disorders Medications Market
1.4.1 Global Dermatological Disorders Medications Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mylan Pharmaceuticals
2.1.1 Mylan Pharmaceuticals Details
2.1.2 Mylan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Mylan Pharmaceuticals SWOT Analysis
2.1.4 Mylan Pharmaceuticals Product and Services
2.1.5 Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Almirall
2.3.1 Almirall Details
2.3.2 Almirall Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Almirall SWOT Analysis
2.3.4 Almirall Product and Services
2.3.5 Almirall Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 PharmaDerm
2.5.1 PharmaDerm Details
2.5.2 PharmaDerm Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 PharmaDerm SWOT Analysis
2.5.4 PharmaDerm Product and Services
2.5.5 PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline SWOT Analysis
2.7.4 GlaxoSmithKline Product and Services
2.7.5 GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Barrier Therapeutics
2.8.1 Barrier Therapeutics Details
2.8.2 Barrier Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Barrier Therapeutics SWOT Analysis
2.8.4 Barrier Therapeutics Product and Services
2.8.5 Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bausch Health SWOT Analysis
2.9.4 Bausch Health Product and Services
2.9.5 Bausch Health Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Galderma
2.10.1 Galderma Details
2.10.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Galderma SWOT Analysis
2.10.4 Galderma Product and Services
2.10.5 Galderma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sinclair Pharma
2.12.1 Sinclair Pharma Details
2.12.2 Sinclair Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sinclair Pharma SWOT Analysis
2.12.4 Sinclair Pharma Product and Services
2.12.5 Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dermatological Disorders Medications Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatological Disorders Medications Manufacturer Market Share in 2019
3.3.2 Top 6 Dermatological Disorders Medications Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dermatological Disorders Medications Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatological Disorders Medications Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dermatological Disorders Medications Revenue and Market Share by Regions (2015-2020)
4.2 North America Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
4.3 Europe Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
4.5 South America Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dermatological Disorders Medications Sales, Revenue and Market Share by Country
5.1.1 North America Dermatological Disorders Medications Sales and Market Share by Country (2015-2020)
5.1.2 North America Dermatological Disorders Medications Revenue and Market Share by Country (2015-2020)
5.2 United States Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
5.3 Canada Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
5.4 Mexico Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dermatological Disorders Medications Sales, Revenue and Market Share by Country
6.1.1 Europe Dermatological Disorders Medications Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dermatological Disorders Medications Revenue and Market Share by Country (2015-2020)
6.2 Germany Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
6.3 UK Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
6.4 France Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
6.5 Russia Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
6.6 Italy Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dermatological Disorders Medications Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dermatological Disorders Medications Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dermatological Disorders Medications Revenue and Market Share by Regions (2015-2020)
7.2 China Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
7.3 Japan Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
7.4 Korea Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
7.5 India Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
7.7 Australia Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dermatological Disorders Medications Sales, Revenue and Market Share by Country
8.1.1 South America Dermatological Disorders Medications Sales and Market Share by Country (2015-2020)
8.1.2 South America Dermatological Disorders Medications Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
8.3 Argentina Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dermatological Disorders Medications Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dermatological Disorders Medications Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
9.3 Turkey Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
9.4 Egypt Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
9.5 South Africa Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dermatological Disorders Medications Sales and Market Share by Type (2015-2020)
10.2 Global Dermatological Disorders Medications Revenue and Market Share by Type (2015-2020)
10.3 Global Dermatological Disorders Medications Price by Type (2015-2020)
11 Global Dermatological Disorders Medications Market Segment by Application
11.1 Global Dermatological Disorders Medications Sales Market Share by Application (2015-2020)
11.2 Global Dermatological Disorders Medications Revenue Market Share by Application (2015-2020)
11.3 Global Dermatological Disorders Medications Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dermatological Disorders Medications Sales, Revenue and Growth Rate (2021-2025)
12.2 Dermatological Disorders Medications Market Forecast by Regions (2021-2025)
12.2.1 North America Dermatological Disorders Medications Market Forecast (2021-2025)
12.2.2 Europe Dermatological Disorders Medications Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dermatological Disorders Medications Market Forecast (2021-2025)
12.2.4 South America Dermatological Disorders Medications Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dermatological Disorders Medications Market Forecast (2021-2025)
12.3 Dermatological Disorders Medications Market Forecast by Type (2021-2025)
12.3.1 Global Dermatological Disorders Medications Sales Forecast by Type (2021-2025)
12.3.2 Global Dermatological Disorders Medications Market Share Forecast by Type (2021-2025)
12.4 Dermatological Disorders Medications Market Forecast by Application (2021-2025)
12.4.1 Global Dermatological Disorders Medications Sales Forecast by Application (2021-2025)
12.4.2 Global Dermatological Disorders Medications Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dermatological Disorders Medications Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dermatological Disorders Medications by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dermatological Disorders Medications Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Pharmaceuticals Dermatological Disorders Medications Major Business
Table 9. Mylan Pharmaceuticals Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 10. Mylan Pharmaceuticals SWOT Analysis
Table 11. Mylan Pharmaceuticals Dermatological Disorders Medications Product and Services
Table 12. Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Dermatological Disorders Medications Major Business
Table 15. Bristol-Myers Squibb Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb Dermatological Disorders Medications Product and Services
Table 18. Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Almirall Basic Information, Manufacturing Base and Competitors
Table 20. Almirall Dermatological Disorders Medications Major Business
Table 21. Almirall Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 22. Almirall SWOT Analysis
Table 23. Almirall Dermatological Disorders Medications Product and Services
Table 24. Almirall Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Dermatological Disorders Medications Major Business
Table 27. Pfizer Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Dermatological Disorders Medications Product and Services
Table 30. Pfizer Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. PharmaDerm Basic Information, Manufacturing Base and Competitors
Table 32. PharmaDerm Dermatological Disorders Medications Major Business
Table 33. PharmaDerm Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 34. PharmaDerm SWOT Analysis
Table 35. PharmaDerm Dermatological Disorders Medications Product and Services
Table 36. PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Roche Basic Information, Manufacturing Base and Competitors
Table 38. Roche Dermatological Disorders Medications Major Business
Table 39. Roche Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 40. Roche SWOT Analysis
Table 41. Roche Dermatological Disorders Medications Product and Services
Table 42. Roche Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Dermatological Disorders Medications Major Business
Table 45. GlaxoSmithKline Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 46. GlaxoSmithKline SWOT Analysis
Table 47. GlaxoSmithKline Dermatological Disorders Medications Product and Services
Table 48. GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Barrier Therapeutics Basic Information, Manufacturing Base and Competitors
Table 50. Barrier Therapeutics Dermatological Disorders Medications Major Business
Table 51. Barrier Therapeutics Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 52. Barrier Therapeutics SWOT Analysis
Table 53. Barrier Therapeutics Dermatological Disorders Medications Product and Services
Table 54. Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 56. Bausch Health Dermatological Disorders Medications Major Business
Table 57. Bausch Health Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 58. Bausch Health SWOT Analysis
Table 59. Bausch Health Dermatological Disorders Medications Product and Services
Table 60. Bausch Health Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Galderma Basic Information, Manufacturing Base and Competitors
Table 62. Galderma Dermatological Disorders Medications Major Business
Table 63. Galderma Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 64. Galderma SWOT Analysis
Table 65. Galderma Dermatological Disorders Medications Product and Services
Table 66. Galderma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Dermatological Disorders Medications Major Business
Table 69. Novartis Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 70. Novartis SWOT Analysis
Table 71. Novartis Dermatological Disorders Medications Product and Services
Table 72. Novartis Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sinclair Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Sinclair Pharma Dermatological Disorders Medications Major Business
Table 75. Sinclair Pharma Dermatological Disorders Medications Total Revenue (USD Million) (2018-2019)
Table 76. Sinclair Pharma SWOT Analysis
Table 77. Sinclair Pharma Dermatological Disorders Medications Product and Services
Table 78. Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Dermatological Disorders Medications Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Dermatological Disorders Medications Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Dermatological Disorders Medications Sales by Regions (2015-2020) (K Units)
Table 82. Global Dermatological Disorders Medications Sales Market Share by Regions (2015-2020)
Table 83. Global Dermatological Disorders Medications Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Dermatological Disorders Medications Sales by Countries (2015-2020) (K Units)
Table 85. North America Dermatological Disorders Medications Sales Market Share by Countries (2015-2020)
Table 86. North America Dermatological Disorders Medications Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Dermatological Disorders Medications Revenue Market Share by Countries (2015-2020)
Table 88. Europe Dermatological Disorders Medications Sales by Countries (2015-2020) (K Units)
Table 89. Europe Dermatological Disorders Medications Sales Market Share by Countries (2015-2020)
Table 90. Europe Dermatological Disorders Medications Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Dermatological Disorders Medications Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Dermatological Disorders Medications Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Dermatological Disorders Medications Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Dermatological Disorders Medications Sales by Countries (2015-2020) (K Units)
Table 95. South America Dermatological Disorders Medications Sales Market Share by Countries (2015-2020)
Table 96. South America Dermatological Disorders Medications Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Dermatological Disorders Medications Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Dermatological Disorders Medications Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Dermatological Disorders Medications Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Dermatological Disorders Medications Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Dermatological Disorders Medications Revenue Market Share by Countries (2015-2020)
Table 102. Global Dermatological Disorders Medications Sales by Type (2015-2020) (K Units)
Table 103. Global Dermatological Disorders Medications Sales Share by Type (2015-2020)
Table 104. Global Dermatological Disorders Medications Revenue by Type (2015-2020) (USD Million)
Table 105. Global Dermatological Disorders Medications Revenue Share by Type (2015-2020)
Table 106. Global Dermatological Disorders Medications Sales by Application (2015-2020) (K Units)
Table 107. Global Dermatological Disorders Medications Sales Share by Application (2015-2020)
Table 108. Global Dermatological Disorders Medications Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Dermatological Disorders Medications Market Share Forecast by Regions (2021-2025)
Table 110. Global Dermatological Disorders Medications Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Dermatological Disorders Medications Market Share Forecast by Type (2021-2025)
Table 112. Global Dermatological Disorders Medications Sales Forecast by Application (2021-2025)
Table 113. Global Dermatological Disorders Medications Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dermatological Disorders Medications Picture
Figure 2. Global Sales Market Share of Dermatological Disorders Medications by Type in 2019
Figure 3. Prescription Drugs Picture
Figure 4. Over-The-Counter Drugs Picture
Figure 5. Dermatological Disorders Medications Sales Market Share by Application in 2018
Figure 6. Hospital Pharmacies Picture
Figure 7. Online Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Global Dermatological Disorders Medications Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Dermatological Disorders Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Dermatological Disorders Medications Sales Market Share by Manufacturer in 2019
Figure 30. Global Dermatological Disorders Medications Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Dermatological Disorders Medications Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Dermatological Disorders Medications Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Dermatological Disorders Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Dermatological Disorders Medications Revenue Market Share by Regions (2015-2020)
Figure 37. Global Dermatological Disorders Medications Revenue Market Share by Regions in 2018
Figure 38. North America Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
Figure 39. Europe Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
Figure 41. South America Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Dermatological Disorders Medications Sales and Growth Rate (2015-2020)
Figure 43. North America Dermatological Disorders Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Dermatological Disorders Medications Sales Market Share by Countries (2015-2020)
Figure 45. North America Dermatological Disorders Medications Sales Market Share by Countries in 2018
Figure 46. North America Dermatological Disorders Medications Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Dermatological Disorders Medications Revenue Market Share by Countries in 2018
Figure 48. United States Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Dermatological Disorders Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Dermatological Disorders Medications Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Dermatological Disorders Medications Revenue Market Share by Countries in 2019
Figure 54. Germany Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Dermatological Disorders Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Dermatological Disorders Medications Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Dermatological Disorders Medications Revenue Market Share by Regions 2019
Figure 62. China Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Dermatological Disorders Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Dermatological Disorders Medications Sales Market Share by Countries in 2019
Figure 69. South America Dermatological Disorders Medications Revenue Market Share by Countries in 2019
Figure 70. Brazil Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Dermatological Disorders Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Dermatological Disorders Medications Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Dermatological Disorders Medications Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Dermatological Disorders Medications Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Dermatological Disorders Medications Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Dermatological Disorders Medications Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Dermatological Disorders Medications Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Dermatological Disorders Medications Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Dermatological Disorders Medications Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Dermatological Disorders Medications Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Dermatological Disorders Medications Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Dermatological Disorders Medications Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
処方用皮膚科薬品の世界市場 2020年 Market Overview The global Prescription Dermatological Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Presc…- 処方用関節炎薬の世界市場 2020年 Market Overview The global Prescription Arthritis Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescripti…
- OTC鎮痛薬の世界市場 2020年 Market Overview The global OTC Pain Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The OTC Pain Medications mar…
- ペプチドベース胃腸障害治療薬の世界市場 2020年 Market Overview The global Peptide Based Gastrointestinal Disorders Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…
- 抗感染薬の世界市場 2020年 Market Overview The global Anti-Infective Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Infective Med…